Montelukast EP IMpurity E
|
|
|
- CAS-Nr.
- 1187586-58-8
- Englisch Name:
- Montelukast EP IMpurity E
- Synonyma:
- Montelukast imp E;Montelukast Impurity E;Montelukast EP IMpurity E;Michael Adduct R,S-Isomer;(R,S)-Montelukast Bis-sulfide;Montelukast Sodium EP impurity E;USP Montelukast Related Compound D;Montelukast Impurity 5(EP Impurity E);Montelukast Impurity 5（Montelukast EP Impurity E）;Montelukast EP Impurity E/ Montelukast Related Compound D (Michael Adduct (R,S)-Isomer)
- CBNumber:
- CB32674958
- Summenformel:
- C41H46ClNO5S2
- Molgewicht:
- 732.39
- MOL-Datei:
- 1187586-58-8.mol
|
Montelukast EP IMpurity E Eigenschaften
- Schmelzpunkt:
- >60°C (dec.)
- Siedepunkt:
- 856.9±65.0 °C(Predicted)
- Dichte
- 1.302±0.06 g/cm3(Predicted)
- storage temp.
- Refrigerator
- Löslichkeit
- Chloroform (Slightly), Methanol (Slightly)
- pka
- 4.76±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Pale Yellow to Yellow
Sicherheit
Montelukast EP IMpurity E Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
(R,S)-Montelukast Bis-sulfide (Montelukast EP Impurity E; Montelukast USP Related Compound D) is an impurity of Montelukast and is a part of the diastereomer mixture Montelukast Bis-Sulfide (M567985).
Montelukast EP IMpurity E Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Montelukast EP IMpurity E Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 57)Lieferanten
- Montelukast EP IMpurity E
- (R,S)-Montelukast Bis-sulfide
- 2-(1-((((R)-1-(3-((S)-1-(((1-(carboxymethyl)cyclopropyl)methyl)thio)-2-(7-chloroquinolin-2-yl)ethyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetic acid
- Montelukast Impurity E
- 1-[[[(1R)-1-[3-[(1S)-1-[[[1-(Carboxymethyl)cyclopropyl]methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl) phenyl] propyl] thio]methyl]-cyclopropaneacetic acid
- Montelukast Sodium EP impurity E
- Montelukast Impurity 5(EP Impurity E)
- Montelukast impurity 5/Montelukast EP Impurity E/Montelukast R,S-Isomer/
1-[[[(1R)-1-[3-[(1S)-1-[[[1-(Carboxymethyl)cyclopropyl]methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneacetic
- Montelukast Impurity 5（Montelukast EP Impurity E）
- Montelukast impurity 5/Montelukast EP Impurity E/Montelukast R,S-Isomer/
1-[[[(1R)-1-[3-[(1S)-1-[[[1-(Carboxymethyl)cyclopropyl]methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneacetic Acid
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1S)-1-[[[1-(carboxymethyl)cyclopropyl]methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-
- USP Montelukast Related Compound D
- Montelukast imp E
- Montelukast EP Impurity E/ Montelukast Related Compound D (Michael Adduct (R,S)-Isomer)
- Michael Adduct R,S-Isomer
- 1187586-58-8
